• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

tetano

Editor, Senior Moderator
BMC Infect Dis. 2016 Sep 22;16(1):503.
[h=1]Classification and Regression Tree (CART) analysis to predict influenza in primary care patients.[/h] Zimmerman RK[SUP]1,[/SUP][SUP]2[/SUP], Balasubramani GK[SUP]3[/SUP], Nowalk MP[SUP]3[/SUP], Eng H[SUP]3[/SUP], Urbanski L[SUP]4[/SUP], Jackson ML[SUP]5[/SUP], Jackson LA[SUP]5[/SUP], McLean HQ[SUP]6[/SUP], Belongia EA[SUP]6[/SUP], Monto AS[SUP]7[/SUP], Malosh RE[SUP]7[/SUP], Gaglani M[SUP]8[/SUP], Clipper L[SUP]8[/SUP], Flannery B[SUP]9[/SUP], Wisniewski SR[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The use of neuraminidase-inhibiting anti-viral medication to treat influenza is relatively infrequent. Rapid, cost-effective methods for diagnosing influenza are needed to enable appropriate prescribing. Multi-viral respiratory panels using reverse transcription polymerase chain reaction (PCR) assays to diagnose influenza are accurate but expensive and more time-consuming than low sensitivity rapid influenza tests. Influenza clinical decision algorithms are both rapid and inexpensive, but most are based on regression analyses that do not account for higher order interactions. This study used classification and regression trees (CART) modeling to estimate probabilities of influenza.
[h=4]METHODS:[/h] Eligible enrollees ≥ 5 years old (n = 4,173) who presented at ambulatory centers for treatment of acute respiratory illness (≤7 days) with cough or fever in 2011-2012, provided nasal and pharyngeal swabs for PCR testing for influenza, information on demographics, symptoms, personal characteristics and self-reported influenza vaccination status.
[h=4]RESULTS:[/h] Antiviral medication was prescribed for just 15 % of those with PCR-confirmed influenza. An algorithm that included fever, cough, and fatigue had sensitivity of 84 %, specificity of 48 %, positive predictive value (PPV) of 23 % and negative predictive value (NPV) of 94 % for the development sample.
[h=4]CONCLUSIONS:[/h] The CART algorithm has good sensitivity and high NPV, but low PPV for identifying influenza among outpatients ≥5 years. Thus, it is good at identifying a group who do not need testing or antivirals and had fair to good predictive performance for influenza. Further testing of the algorithm in other influenza seasons would help to optimize decisions for lab testing or treatment.


[h=4]KEYWORDS:[/h] Clinical decision tools; Influenza; Recursive partitioning

PMID: 27659721 DOI: 10.1186/s12879-016-1839-x
[PubMed - as supplied by publisher]
 
Back
Top Bottom